AGP Limited (KASE: AGP)
Health Care · Pharmaceuticals · PK
PKRs177.94
-5.56% today · -15.0% 1Y
AGP Limited (KASE: AGP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $179.62M.
Over the last twelve months the share price has lost 15.0%, trading between 163.00 and 258.67.
Tweenvest scores AGP Limited across four factors: quality 73/100, value 56/100, growth 83/100, dividend 83/100. Its strongest factor is growth.
AGP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $179.62M
- Revenue (TTM)
- $102.45M
- P/E
- 13.32
- EPS
- 13.36
- Dividend yield
- 4.50%
- Beta (5Y)
- 0.49
- 52-week high
- PKRs258.67
- 52-week low
- PKRs163.00
- Avg volume (3M)
- —
- Shares outstanding
- 280.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,226.58 | -0.57% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.58 | -0.57% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.68 | -1.77% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.77% |
Figures last refreshed Aug 18, 2026.